23948sdkhjf
Köp Köp åtkomst
  • {{ window.visitor.ipAccess.corporateClient.name }}

  • Welcome to our Corporate client solution

    Your IP is registered with the company mentioned above and provides access to Life Science Sweden.

  • Click here to go to sign-up
  • {{ window.visitor.ipAccess.corporateClient.name }}

  • Welcome to our Corporate client solution

    Your IP is registered with the company mentioned above and provides access to Life Science Sweden.

  • Click here to go to sign-up
Logga in eller skapa för att spara artiklar
Få tillgång till allt innehåll på Life Science Sweden
Ingen bindningstid eller kortinformation krävs
Prova Life Science Sweden nu
Gäller endast personlig prenumeration.
Kontakta oss för en företagslösning.
News in English

Developing rapid diagnostics for sepsis – “Every hour counts”

Finding the right antibiotic in the right dose – with an ultra-fast analysis method. Gradientech's product solution is currently used in routine diagnostics at several hospitals in Europe – and the next target is the US market.

The Uppsala-based company Gradientech has developed a method for ultra-rapid antibiotic susceptibility testing, which aims to ensure that sepsis patients, in particular, can receive the optimal antibiotic treatment.

CEO Sara Thorslund co-founded the company in 2009, and at that time the basic method that has been developed over time and is now used in the company's main product QuickMIC was already in place. At the Lab & Diagnostics of the Future conference on March 18, she will talk about the company's technology.

BREAKING
{{ article.headline }}
0.088